regaine for women extra strength scalp foam 5% w/w cutaneous foam
jntl consumer health i (ireland) limited - minoxidil - cutaneous foam - other dermatologicals; minoxidil
regaine for women regular strength 2% w/v cutaneous solution
jntl consumer health i (ireland) limited - minoxidil - cutaneous solution - other dermatologicals; minoxidil
women-care capsules keyi
science arts co pte ltd - capsules
women's daily multi
healthy life group pty ltd - angelica polymorpha,betacarotene,biotin,borax,calcium ascorbate dihydrate,calcium citrate,calcium pantothenate,cholecalciferol,chromic chloride,citrus bioflavonoids extract,cupric sulfate pentahydrate,cyanocobalamin,d-alpha-tocopheryl acid -
women's fish oil with epo
evolution health pty ltd - concentrated omega-3 triglycerides - fish,evening primrose oil -
women's everyday multi
pure vitamins - angelica polymorpha,biotin,borax,calcium ascorbate,calcium carbonate,calcium pantothenate,cholecalciferol,choline bitartrate,chromium picolinate,citrus bioflavonoids extract,cyanocobalamin,d-alpha-tocopheryl acid succinate,dunaliella -
women's multivitamin vegicap softgel
catalent australia pty ltd - biotin,calcium carbonate,calcium hydrogen phosphate anhydrous,calcium pantothenate,camellia sinensis,cholecalciferol,choline bitartrate,chromium picolinate,cupric sulfate anhydrous,cyanocobalamin,d-alpha-tocopherol,ferrous fumarate,folic -
androcur cyproterone acetate 50 mg tablet blister pack
bayer australia ltd - cyproterone acetate, quantity: 50 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; maize starch; colloidal anhydrous silica; povidone - women: moderately severe to severe signs of androgenization. moderately severe/severe forms of hirsutism.moderately severe/severe androgen-dependent loss of scalp hair (moderately severe/severe androgenic alopecia). moderately severe/severe forms of acne and/or seborrhoea associated with other features of androgenization.cyproterone acetate inhibits the influence of male sex hormones which are also produced by the female. it is thus possible to treat diseases in women caused either by increased production of androgens or a particular sensitivity to these hormones. hirsutism and alopecia may be expected to recur over a period of time after cessation of treatment.if androcur is taken during pregnancy, the properties of the preparation may lead to signs of feminisation in the male foetus. therefore, in women of childbearing potential, pregnancy must be excluded at the commencement of treatment and ethinyloestradiol taken as well to ensure contraception. this also promotes regular menstruation.men:reduction of drive in sexual deviations androcur reduces the force of the sexual urge in men with sexual deviations. whilst under treatment the man can control himself better in a predisposing stimulatory situation, but there is no influence on any deviating direction of sexual drive. abnormal patterns of sexual behaviour require treatment when they are distressing to the patient. a pre-requisite for therapy is the desire by the patient for treatment.androcur therapy should be supplemented by psychotherapeutic and sociotherapeutic measures in order to exploit the period of reduced drive for personal and social re-orientation.inoperable prostatic carcinoma to suppress "flare" with initial lhrh analogue therapy in long term palliative treatment where lhrh analogues or surgery are ineffective, not tolerated, contraindicated or where oral therapy is preferred in the treatment of hot flushes in patients treated with lhrh analogues or who have had orchidectomy.
women's all in one plus ginseng
catalent australia pty ltd - ascorbic acid,calcium hydrogen phosphate anhydrous,cyanocobalamin,dl-alpha tocopheryl acetate,fish oil - natural,folic acid,magnesium sulfate trihydrate,manganese sulfate monohydrate,nicotinamide,panax ginseng,potassium sulfate,pyridoxine -